Knowledge Acquisition for Clinical-Trial Selection Savvas Nikiforou Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Jeffrey P. Krischer.

Slides:



Advertisements
Similar presentations
When Should a Clinical Trial Design with Pre-Stratification be Used? Group 1.
Advertisements

An Outline for: A User-Based Systems Approach to the Evaluation, Selection, and Institutionalization of Safer Medical Devices.
Enter question text... 1.Enter answer text.... Enter question text... 1.Enter answer text...
Entering Data for Analysis Annie Herbert Medical Statistician Research & Development Support Unit Salford Royal (Hope) Hospitals NHS Foundation Trust
New Features and Enhancements
Enter question text... 1.Enter answer text.... Enter question text... 1.Enter answer text...
Survivorship Simplified: Tools and Resources Across the Continuum Thomas P. Sellers, MPA 12-Year Cancer Survivor President and CEO National Coalition for.
RESTRAINT DOCUMENTATION Please see Patient Care Policy R-2 The Restraint Documentation screens have been updated to reflect recent policy changes for ordering.
Open Specimen Query and Reporting Snehil Gupta Center For Biomedical Informatics Washington University in St. Louis.
Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.
Coding of Selection Criteria for Cancer Treatment Plans Savvas Nikiforou.
I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=
A Cost-Effective Agent for Clinical Trial Assignment Princeton K. Kokku Lawrence O. Hall Dmitry B. Goldgof Eugene Fink Jeffrey P. Krischer.
I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=
Breast cancer and medical second opinion
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
AJCC TNM Staging 7th Edition Breast Case #3
Impact of Cancer Diagnosis and Chemotherapy on Mammography Use Xinhua Yu, M.B., Ph.D. A. Marshall McBean, M.D., M.Sc. Beth A. Virnig, Ph.D., M.P.H Division.
1 Agenda Views Pages Web Parts Navigation Office Wrap-Up.
AJCC TNM Staging 7th Edition Melanoma Case #2
AJCC Staging Moments AJCC TNM Staging 7th Edition Melanoma Case #3 Contributors: Jeffrey E. Gershenwald, MD University of Texas MD Anderson Cancer Center,
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
ACRIN 6657/CALGB Consent for Research Study Contrast-Enhanced Breast MRI and MRS: A Correlative Science Studies to Characterize Tumor Response in.
Uncovering Age-Specific Invasive and DCIS Breast Cancer Rules Using Inductive Logic Programming Houssam Nassif, David Page, Mehmet Ayvaci, Jude Shavlik,
Breast cancer patient pathway
Driving the Transition to Individualized Cancer Treatment by Addressing Critical Questions 1 Do I need surgery? chemotherapy? radiation? INVASIVE BREAST.
EHR Reminders - Copying and Customizing National Reminders LCDR Susan Pierce-Richards, MSN, ARNP.
GLIF – GELLO – Archetypes Jared Davison Medical-Objects Australia.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Clinical Questions What is the superior surgical approach for postmenopausal women with early stage endometrial cancer in terms of patient quality of life?
Comparing the Positive Effect of Vitamin E and Flouxetine in the Treatment of Hot Flashes in Breast Cancer Patients. Comparing the Positive Effect of.
Medical Expert Systems Eddie Lai. History  1950s – scientists tried to use computers for “probabilistic reasoning and statistical pattern recognition”
Progesterone and Traumatic Brain Injury. from: Progesterone is a female hormone important for the regulation of.
Oral Bisphosphonate and Breast Cancer: Prospective Results from the Women’s Health Initiative (WHI) Chlebowski RT et al. SABCS 2009; Abstract 21.
Data Collection Tools and Creation of a Usable Database Adam Schlichting University of Illinois at Chicago Department of Emergency Medicine Last updated:
Objectives Abstract Background Materials & Methods References 1.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of.
“ Back Pain” Expert System G.I. Nazarenko, G.S. Osipov A.G. Nazarenko, A.I. Molodchenkov.
Systematic Reviews.
Post-Resection CA 19-9 Predicts Overall Survival in Patients Treated with Adjuvant Chemoradiation; RTOG 9704 A. Berger, K. Winter, J. Hoffman, W. Regine,
EDRN Approaches to Biomarker Validation DMCC Statisticians Fred Hutchinson Cancer Research Center Margaret Pepe Ziding Feng, Mark Thornquist, Yingye Zheng,
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2013 – December 31, 2013 Compiled by Uzma Nazim, M.D.
Androgen Therapy for Low Sexual Desire: A Concerned Physician’s View James A. Simon, M.D. Clinical Professor George Washington University Washington, DC.
Cardiac events after treatment with high dose radiation therapy +/- chemotherapy for non-small cell lung cancer Linglong Tang, Anwen Liu, Daniel Gomez,
The Bioinformatics System for the Research of Interleukin 1 Gene Polymorphisms and Related Factors in Gastric Cancers Kuan-Liang Kuo, MD 1, 2 (
Support of EMG cases collection and distribution Mária Bieliková, Pavol Návrat, Mária Smolárová Slovak University of Technology Bratislava, Slovakia
Urinary Tract System Bladder Cancer.
Health Budgets & Financial Policy CPT/HCPCS 2010 Updates 12 January 2010 – 0800 & 1400 & 2100 EST 14 January 2010 – 0800 & 1400 Bridge Number:
August 2000Puget Sound VAHCS VA FileMan 1 1 VA FileMan 1 Introduction to VA FileMan Puget Sound VAHCS Seattle, WA August 2000 Version 3 Contributors: Valerie.
Adjuvant Radiation is Not Associated with Improved Survival in Patients with Positive Margins Following Lobectomy for Stage I & II Non-Small Cell Lung.
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2014 – December 31, 2014 Compiled by L.Day, RN BSN CCM CCRP OCN 1.
1 XIII: Electronic Resources Managing Trials and Evaluations.
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2009 – December 31, 2009.
Automated Selection of Patients for Clinical Trials Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Bhavesh D. Goswami Matthew Boonstra Jeffrey P. Krischer.
National Reminders- Reminder Reports. Reminder Reports on Main Menu CFM Reminder Computed Finding Management... DEF Reminder Definition Management...
Should liver metastases of breast cancer be biopsied to improve treatment choice? M. A. Locatelli, G. Curigliano, L. Fumagalli, V. Bagnardi, G. Aurilio,
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2012 – December 31, 2012 Compiled by Uzma Nazim, M.D.
1 DRAFT SLIDES FOR NDA ADVISORY COMMITTEE PRESENTATIONS.
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2010 – December 31, 2010 Compiled by Lynn Day, RN BSN CCM CCRP.
Peer Pressure and Alcohol use influence on college students’ sexual behavior By: Lauren Hauser.
What to Expect When Expecting ESL Students: Practical Suggestions for Accommodating English Language Learners in the Regular Classroom Created by Jenny.
SAGE Nick Beard Vice President, IDX Systems Corp..
Analyzing Data. Learning Objectives You will learn to: – Import from excel – Add, move, recode, label, and compute variables – Perform descriptive analyses.
Presented at the NAACCR Annual Conference Quebec City June 22, 2010.
Early Identification of Patients for Clinical Trials and Special Studies with Custom Metafile NAACCR, June 18, 2009 Alan R. Houser, MA, MPH C/NET Solutions.
Presented By Shin Fujita at 2016 ASCO Annual Meeting
Patient & tumor characteristics (n=39)
5 Minute Math 3. Place the following fractions in increasing order: 3/4 2/5 6/10 17/20 1/2 4. Match each colored shape with one of the following fractions:
Medical Statistic.
سرطان الثدي Breast Cancer
Breast Multidisciplinary Team Meetings
Presentation transcript:

Knowledge Acquisition for Clinical-Trial Selection Savvas Nikiforou Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Jeffrey P. Krischer

Expert System The system analyzes a patient’s data and determines whether the patient is eligible for clinical trials at the H. Lee Moffitt Cancer Center.

Expert System Guides a clinician through related questions Identifies appropriate medical tests Selects matching clinical trials Minimizes pain and cost of selection process

Outline Eligibility decisions Knowledge base Knowledge entry Experiments

Example: Eligibility Criteria Female, older than 30 No prior surgery Breast cancer, stage II or III

Example: Questions Sex: Age: Female Male 25

Example: Conclusion Patient is not eligible

Example: Questions Sex: Age: 35 Female Male

Example: Questions Cancer stage: Prior surgery? Yes No I II III IV

Example: Conclusion Patient is eligible

Full Functionality Orders and groups the questions Considers multiple clinical trials

Outline Eligibility decisions Knowledge base Knowledge entry Experiments

Main Objects Questions Medical tests Eligibility criteria

Types of Questions Yes / No Multiple choice Numeric

Tests A medical test answers several questions. It involves certain pain and cost.

Eligibility Criteria A logical expression that determines eligibility for a specific clinical trial

Example: Criteria AND Age > 30 Prior-surgery = NO OR Cancer-stage = II Cancer-stage = III

Outline Eligibility decisions Knowledge base Knowledge entry Experiments

Tests and Questions Adding tests Modifying a test Adding yes/no questions Adding multiple choice questions Adding numeric questions Deleting questions

Adding Tests Test name: Cost: Pain: Yes/NoM-ChoiceNumericDeleting Adding Modifying Mammogram

Adding Yes/No Questions Breast cancer? Text Yes/NoM-ChoiceNumeric Adding Modifying Deleting

Adding Multiple Choice Questions TextOptions Yes/NoM-ChoiceNumeric Adding Modifying Cancer stage I II III IV Deleting

Adding Numeric Questions TextMinMax Tumor size 250 Yes/NoM-ChoiceNumeric Adding Modifying Deleting

Eligibility Criteria Adding eligibility criteria Selecting tests Deleting expressions Editing questions Defining an expression Selecting questions

Example: Eligibility Criteria Female, older than 30 Breast cancer, stage II Post-menopausal or surgically sterilized

Adding Eligibility Criteria Adding criteria Selecting tests 001Clinical trial A Trial numberTrial name Deleting expressions Editing questions Defining an expression Selecting questions

Selecting Tests General questions Blood test Mammogram Biopsy Urine test Adding criteria Selecting tests Deleting expressions Editing questions Defining an expression Selecting questions

Selecting Questions I II III IV Cancer stage: Age:From:To: Post-menopausal? Yes Surgically sterilized? Yes Adding criteria Selecting tests Deleting expressions Editing questions Defining an expression Selecting questions Prior surgery? No Yes

Defining an Expression Cancer-stage = II Surgically-sterilized = YES Post-menopausal = YES Age > 30 Adding criteria Selecting tests Deleting expressions Editing questions Defining an expression Selecting questions

Defining an Expression AND Adding criteria Selecting tests Deleting expressions Editing questions Defining an expression Selecting questions Cancer-stage = II Surgically-sterilized = YES Post-menopausal = YES Age > 30

Defining an Expression Adding criteria Selecting tests Deleting expressions Editing questions Defining an expression Selecting questions Surgically-sterilized = YES Post-menopausal = YES AND Age > 30 Cancer-stage = II

Defining an Expression Adding criteria Selecting tests Deleting expressions Editing questions Defining an expression Selecting questions Surgically-sterilized = YES AND Age > 30 OR Post-menopausal = YES Cancer-stage = II

Defining an Expression Adding criteria Selecting tests Deleting expressions Editing questions Defining an expression Selecting questions AND Age > 30 OR Post-menopausal = YES Cancer-stage = II Surgically-sterilized = YES

Outline Eligibility decisions Knowledge base Knowledge entry Experiments

Performance of sixteen novice users Entering tests and questions Entering eligibility criteria

Entering Tests and Questions Learning curve

Entering Eligibility Criteria Learning curve

Summary Learning time: 1 hour Adding a test: 2 to 10 minutes Building a knowledge base for Moffitt breast-cancer trials: 8 to 10 hours Adding eligibility criteria: 30 to 60 minutes

Main Results Formal model of selection criteria Representation of related knowledge Friendly interface for knowledge entry